Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Neoadjuvant chemoradiotherapy in patients with surgically treated T4 esophageal squamous cell carcinnoma].

Nihon Geka Gakkai zasshi - 1 Mar 2002

Shiozaki Hitoshi, Yano Masahiko

Abstract excerpt

BACKGROUND: Esophageal cancer carries one of the poorest prognoses among digestive tract malignancies. Recent evidence suggests that the addition of nonsurgical treatment to surgery may improve resection rates, reduce the risk of recurrence, and improve survival. METHODS: From August 1989 to December 2000, 69 patients with locally advanced (T4) esophageal squamous cell carcinoma were treated with combined...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Squamous Cell
Share to Chemotherapy, Adjuvant
Share to Esophageal Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, p53

Share to Neoadjuvant Therapy

Share to Neoplasm Staging

Share to Prognosis

Share to Radiotherapy, Adjuvant

Source

Identifiers

PMID: 11968758

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Neoadjuvant chemoradiotherapy in patients with surgically treated T4 esophageal squamous cell carcinnoma].PMID 11968758Read ↗

Prognostic value of p53 mutations in patients with locally advanced esophageal carcinoma treated with definitive chemoradiotherapy.Semantic proximity Read ↗

Association of p53 protein expression with responses and survival of patients with locally advanced esophageal carcinoma treated with chemoradiotherapy.Semantic proximity Read ↗

Outcomes of Definitive Chemoradiotherapy for Stage Iva (T4b Vs N4) Esophageal Cancer Based on the Japanese Classification System: A Retrospective Single-center Study Semantic proximity Read ↗

[The association between polymorphism of transforming growth factor-β1 and radiochemotherapy response and survival in esophageal squamous cell carcinoma patients].Semantic proximity Read ↗

ERCC1 and XRCC1 gene polymorphisms predict response to neoadjuvant radiochemotherapy in esophageal cancer.Semantic proximity Read ↗

Postoperative chemotherapy vs chemoradiotherapy for thoracic esophageal cancer: a prospective randomized clinical trial.Semantic proximity Read ↗

DNA repair gene and MTHFR gene polymorphisms as prognostic markers in locally advanced adenocarcinoma of the esophagus or stomach treated with cisplatin and 5-fluorouracil-based neoadjuvant chemotherapy.Semantic proximity Read ↗

Epidermal growth factor receptor, p53 mutation, and pathological response predict survival in patients with locally advanced esophageal cancer treated with preoperative chemoradiotherapy.Semantic proximity Read ↗

p53 Mutation status predicts pathological response to chemoradiotherapy in locally advanced esophageal cancer.Semantic proximity Read ↗

[An appropriate chemotherapy for esophageal cancer from a histological standpoint].Semantic proximity Read ↗

p53 sequence analysis predicts treatment response and outcome of patients with esophageal carcinoma.Semantic proximity Read ↗

Neoadjuvant radiochemotherapy in adenocarcinoma of the esophagus: ERCC1 gene polymorphisms for prediction of response and prognosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.